Literature DB >> 30421029

Hereditary clear cell meningiomas in a single family: three-cases report.

Takuro Inoue1, Satoshi Shitara2, Michio Ozeki3, Akifumi Nozawa3, Toshiyuki Fukao3, Takanori Fukushima4.   

Abstract

Clear cell meningiomas (CCMs) are rare subtypes of meningiomas and usually treated by maximum safely achievable tumor resection. We here present three hereditary cases with CCMs which were confirmed by Sanger sequencing of lymphocyte DNA. Gross total resection was achieved in a 5-year-old son with a spinal CCM and a 34-year-old father with a CCM in the cerebellopontine angle (CPA). For a 14-year-old daughter with CCM in the CPA, total resection was not achieved due to its large size. Early detection by screening high-risk family with CCM is strongly recommended.

Entities:  

Keywords:  Clear cell meningioma; Familial; Gene mutation; Hereditary; Intracranial; Intraspinal

Mesh:

Substances:

Year:  2018        PMID: 30421029     DOI: 10.1007/s00701-018-3727-1

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  4 in total

Review 1.  Rare intraspinal clear cell meningioma in children: a case report and literature review.

Authors:  Zheng Hao; Si Hu; Nian-Zu Yu
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

2.  Intraoperative Anatomical Findings in Pediatric Clear Cell Meningioma of the Lumbar Spine: Case Report and Literature Review.

Authors:  Takahiro Tsuchiya; Syunsuke Ikeda; Ayako Isoo; Hiroshi Sakakibara; Satoko Kumada; Takashi Komori; Keisuke Takai
Journal:  NMC Case Rep J       Date:  2021-08-24

3.  Spinal clear cell meningioma without dural attachment: a case report and literature review.

Authors:  Kais Maamri; Mohamed Amine Hadj Taieb; Amine Trifa; Ghassen Elkahla; Manel Njima; Mehdi Darmoul
Journal:  Radiol Case Rep       Date:  2022-03-25

4.  Familial Pediatric Clear Cell Meningioma With Germline SMARCE1 Mutation in the United States.

Authors:  Pournima Navalkele; Miguel Guzman; Amelia Kirby; Hailey Pinz; Joanna Kemp
Journal:  J Neuropathol Exp Neurol       Date:  2020-11-01       Impact factor: 3.685

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.